Lymph node ratio is a stronger prognotic factor than microsatellite instability in colorectal cancer patients: Results from a 7 years follow-up study

International Journal of Surgery

Volumn 11, Issue 9, 2013, Pages 1016-1021

  Ferri, Mario ^a   Lorenzon, Laura ^a   Onelli, Mariadele Rapazzotti ^a   La Torre, Marco ^a   Mercantini, Paolo ^a   Virgilio, Edoardo ^a   Balducci, Genoveffa ^a   Ruco, Luigi ^a   Ziparo, Vincenzo ^a   Pilozzi, Emanuela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Colorectal cancer; Lymph node ratio; Micro satellite instability

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

COLORECTAL CANCER; LYMPH NODE RATIO; MICRO-SATELLITE INSTABILITY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PROGNOSIS;

EID: 84887184133     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2013.05.031     Document Type: Article

References (28)

1. AIRTUM Itumori in Italia: Rapporto 2006, http://www.registri-tumori.it/incidenza1998-2002/gruppi.html.
2. National Comprehensive Cancer Network NCCN guidelines - colon cancer, version 1 2013, http://www.nccn.org.
3. de la Chapelle A., Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. JClin Oncol 2010, 28:3380-3387.
4. Markowitz S.D., Bertagnolli M.M. Molecular origin of cancer: molecular basis of colorectal cancer. NEngl J Med 2009, 361:2449-2460.
5. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993, 260:816-819.
6. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993, 63:558-561.
7. Aaltonen L.A., Salovaara R., Kristo P., Canzian F., Hemminki A., Peltomäki P., et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. NEngl J Med 1998, 338:1481-1487.
8. Umar A., Boland C., Terdiman J., Syngal S., de la Chapelle A., Rüschoff J., et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and micro- satellite instability. JNatl Cancer Inst 2004, 96:261-268.
9. Chou C.L., Lin J.K., Wang H.S., Yang S.H., Li A.F.Y., Chang S.C. Microsatellite instability screening should be done for right-sided colon cancer patients less than 60 years of age. Int J Colorectal Dis 2010, 25:47-52.
10. Al-Sohaily S., Biankin A., Leong R., Kohonen-Corish M., Warusavitarne J. Molecular pathways in colorectal cancer. JGastroenterol Hepatol 2012, 27:1423-1431.
11. Sjo O.H., Merok M.A., Svindland A., Nesbakken A. Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 2012, 55:307-315.
12. American Joint Committee on Cancer Manual for staging of cancer 2009, Springer. 7th ed.
13. Berger A.C., Sigurdson E.R., LeVoyer T., Hanlon A., Mayer R.J., Macdonald J.S., et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. JClin Oncol 2005, 23:8706-8712.
14. Peng J., Xu Y., Guan Z., Zhu J., Wang M., Cai G., et al. Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol 2008, 15:3118-3123.
15. Pilozzi E., Ferri M., Onelli M.R., Mercantini P., Corigliano N., Duranti E., et al. Prognostic significance of 18q LOH in sporadic colorectal carcinoma. Am Surg 2011, 77:38-43.
16. Lorenzon L., Pilozzi E., La Torre M., Ziparo V., Ferri M. Impact and prognostic implications of colon cancers stage II sub-classification through the years. Int J Colorectal Dis 2012, 27:1311-1318.
17. La Torre M., Lorenzon L., Pilozzi E., Barucca V., Cavallini M., Ziparo V., et al. Number of harvested lymph nodes is the main prognostic factor in stage IIa colorectal cancer patients. JSurg Oncol 2012, 15(106):469-474.
18. Cicek M.S., Lindor N.M., Gallinger S., Bapat B., Hopper J.L., Jenkins M.A., et al. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. JMol Diagn 2011, 13:271-281.
19. Ward R., Meagher A., Tomlinson I., O'Connor T., Norrie M., Wu R., et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001, 48:821-829.
20. Kim H.R., Kim H.C., Yun H.R., Kim S.H., Park C.K., Cho Y.B., et al. An alternative pathway in colorectal carcinogenesis based[U+2028]on the mismatch repair system and p53 expression in korean patients with sporadic colorectal cancer. Ann Surg Oncol 2012 Jun 26, [Epub ahead of print].
21. Azzoni C., Bottarelli L., Cecchini S., Silini E.M., Bordi C., Sarli L. Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. Int J Colorectal Dis 2011, 26:445-453.
22. Popat S., Hubner R., Houlston R.S. Systematic review of microsatellite instability and colorectal cancer prognosis. JClin Oncol 2005, 23:609-617.
23. Persiani R., Cananzi F.C.M., Biondi A., Paliani G., Tufo A., Ferrara F., et al. Log odds of positive lymph nodes in colon cancer: a meaningful ratio-based lymph node classification system. World J Surg 2012, 36:667-674.
24. Kim Y.S., Kim J.H., Yoon S.M., Choi E.K., Ahn S.D., Lee S.W., et al. Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009, 74:796-802.
25. Elias E., Mukherji D., Faraj W., Khalife M., Dimassi H., Eloubeidi M., et al. Lymph node ratio is an independent prognostic factor in stage III colorectal cancer patients: a retrospective study from the Middle East. World J Surg Oncol 2012, 10:63.
26. Xicola R.M., Llor X., Pons E., Castells A., Alenda C., Piñol V., et al. Performance of different microsatellite marker panels for detection of mismatch repair - deficient colorectal tumors. JNatl Cancer Inst 2007, 99:244-252.
27. Hoang J.M., Cottu P.H., Thuille B., Salmon R., Thomas G., Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997, 5:300-303.
28. Tomlinson I., Halford S., Aaltonen L., Hawkins N., Ward R. Does MSI-L exist?. JPathol 2002, 197:6-13.